Saturday 17 October 2026 Export MRVI’s income statement to Excel — free account

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024. In the quarter to June 2026, revenue grew 8.53%, EPS grew 70.4%, free cash flow grew 127.6% and total debt fell 45.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.79 0.28 −3.96%

Follow MRVI

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −16.2×
Dividend yield: —
F-score: 2/9
Altman Z: 0.44
Beneish M: −3.30
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	5	3	2	4	+8 more TTM periods Free account
ROE Full definition →	(18.79%)	(23.25%)	(27.53%)	(23.16%)
ROA Full definition →	(10.31%)	(12.50%)	(14.70%)	(11.38%)
ROIC Full definition →	(15.83%)	(22.18%)	(28.16%)	(23.73%)
Return on Tangible Assets Full definition →	(29.80%)	(29.37%)	(32.46%)	(28.61%)
Average Days of Receivables Full definition →	54.44	59.57	50.11	42.75
Free Cash Flow per Share Full definition →	(0.24)	(0.36)	(0.49)	(0.46)
Free Cash Flow Full definition →	(35.84)	(52.60)	(70.72)	(66.33)
Capital Expenditures Full definition →	(10.58)	(13.08)	(13.15)	(16.88)
Other line items
Cash ROIC Full definition →	(5.95%)	(6.53%)	(7.76%)	(6.64%)
Accounts Receivable Turnover Full definition →	7.07	6.61	5.80	7.49
Accounts Payable Turnover Full definition →	14.58	16.03	20.41	17.37
Inventory Turnover Full definition →	3.09	3.21	3.35	3.17
Average Days of Payables Full definition →	19.13	21.52	7.00	19.22
Days of Inventory on Hand Full definition →	110.71	102.02	97.40	108.92
Tax Rate Full definition →	0.00	(0.02)	(0.02)	(0.02)
Research and Development Expense of Revenue Full definition →	7.29%	8.01%	9.37%	9.44%
Selling, General and Administrative Expense of Revenue Full definition →	61.31%	65.77%	78.13%	80.50%
Share Based Compensation of Revenue Full definition →	14.34%	12.95%	16.25%	19.12%
Interest Coverage Full definition →	(4.89)	(6.48)	(7.98)	(6.13)
Operating CF/Net income Full definition →	0.33	0.38	0.44	0.41
Depreciation/Fixed assets Full definition →	0.41	0.41	0.41	(0.31)
Capex/Depreciation Full definition →	(0.18)	(0.22)	(0.21)	0.34
Revenue per Share Full definition →	1.41	1.40	1.29	1.33
Operating CF per Share Full definition →	(0.17)	(0.27)	(0.40)	(0.34)
Capex per Share Full definition →	(0.07)	(0.09)	(0.09)	(0.12)
Capex to Sales Full definition →	0.05	0.06	0.07	0.09

Show all line items

Columns are period end dates

Stockrow Weekly